Cell Therapy Applications Scientist

About PBS Biotech

pbsbiotech.com

PBS Biotech (Progressive Biomanufacturing Systems) designs and supplies scalable single‑use bioreactors and perfusion vessels for development and manufacturing of cell‑based therapies. Their product family spans mini parallel systems (PBS‑0.1, PBS‑0.5, MiniPRO) for closed, rapid process development through larger PBS‑3, PBS‑15 and PBS‑80 units (working volumes ~1.8–80 L) for scale‑up and production. PBS emphasizes closed, disposable designs that simplify setup, reduce contamination risk, and accelerate transferable scale‑up for cell therapy developers and contract manufacturers. The company markets itself as a leading innovator in single‑use bioreactors and was recognized with a 2025 Single‑Use Bioreactors Company of the Year award.